DUALITYBIO-B(09606): It is recommended that the RMB shares be listed on the Sci-Tech Innovation Board with the guidance and acceptance of the Shanghai Regulatory Authority.
Yinge Biotech-B (09606) has announced that the proposed listing of ordinary shares on the Shanghai Stock Exchange STAR Market for trading in Renminbi (recommended for listing). The company is currently receiving guidance from CITIC Securities Co., Ltd., and the guidance has been accepted by the Shanghai Regulatory Bureau of the China Securities Regulatory Commission.
DUALITYBIO-B (09606) has issued an announcement regarding its planned issuance of ordinary shares to be listed on the Shanghai Stock Exchange Science and Technology Innovation Board and traded in Renminbi (proposed listing). The company is currently receiving guidance from CITIC SEC Limited, and the relevant guidance has been approved by the Shanghai Regulatory Bureau of the China Securities Regulatory Commission.
Related Articles

Five major standard systems lead the reform. JD INDUSTRIALS (07618) is establishing a solid foundation for digitalization of the industrial supply chain through standardization.

Roadshow Record | China Green (02411): Store operations are steadily improving, with breakthroughs in multi-dimensional formats, and a clear path for long-term development.

HK Stock Market Move | ZJLD(06979) rises by over 6% again. Institutions point out that the company's actual operations are expected to be better than expected, with a net profit margin in the first half of the year reaching close to 20%.
Five major standard systems lead the reform. JD INDUSTRIALS (07618) is establishing a solid foundation for digitalization of the industrial supply chain through standardization.

Roadshow Record | China Green (02411): Store operations are steadily improving, with breakthroughs in multi-dimensional formats, and a clear path for long-term development.

HK Stock Market Move | ZJLD(06979) rises by over 6% again. Institutions point out that the company's actual operations are expected to be better than expected, with a net profit margin in the first half of the year reaching close to 20%.






